Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases. Jaeckel E, Friedman SL, Hudecek M, Protzer U, et al. J Hepatol 2025;83:1156-1171.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jaeckel E, Friedman SL, Hudecek M, Protzer U, et al. Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases. J Hepatol 2025;83:1156-1171.
PMID: 40545042